An ependymoma is a central nervous system tumor that is most often found in the brain or spinal cord. This cancer starts in the ependymal cells. Ependymal cells line the ventricles in the brain and the central canal in the spinal cord. They help make cerebrospinal fluid (CSF).
Each year about 1,098 people are diagnosed with ependymoma. It can affect both adults and children. In children, the tumor is more common in the lower half of the brain and in adults, it is more common in the spine. More males are diagnosed than females and it is also more common in white and non-Hispanic people.
The cause of ependymoma is not known. Children with neurofibromatosis type 2 (NF2) are at an increased risk of ependymoma because NF2 increases the risk of central nervous system tumors.
There is no way to prevent ependymoma because there are no known risk factors besides NF2.
There are no recommended screening tests for ependymoma. A child won't be tested unless they are showing signs or symptoms of the disease.
The symptoms of ependymoma vary from child to child. They can be caused by pressure on a certain part of the brain from the tumor. Some symptoms include:
Each child can have different symptoms. If your child is having any changes in their normal activity, growth, or is having any changes in health, they should be seen by their provider.
A number of tests can be used to help diagnose ependymoma:
Staging is often used in cancer to help create a treatment plan. Staging takes into account how large a tumor is, how it looks under a microscope and if it has spread. There is no standard staging system for ependymoma.
The World Health Organization groups these tumors into 5 subtypes:
The tumor may also be given a grade. This describes how abnormal the cancer cells look under a microscope. The World Health Organization has 3 grades for ependymoma:
The classification and grade information will help guide a treatment plan.
It is important to find a pediatric facility that has experience treating patients with ependymoma. A team of specialists, along with you and your child, will determine the best treatment plan. A major factor when determining the treatment plan is whether the whole tumor can be removed with surgery. Something to consider when planning a treatment course is that there is potential for late or long-term side effects, meaning side effects that can occur after treatment has ended. Late effects of treatment for ependymoma can include issues with hearing, thyroid problems, neurological issues, fertility problems, issues with growth and development, and in rare cases a second cancer, amongst others. The provider should speak about these possible side effects.
Surgery to remove the tumor is often the treatment of choice. In some cases a tumor can only be partially removed or not removed due to size or its location in the brain. In those cases other treatments will be used. Surgery to remove the tumor is called a craniotomy. Part of the skull is removed and tools are used to remove the tumor.
Radiation is the use of high-energy x-rays to kill cancer cells. It can be used to treat ependymoma that can't be removed by surgery. If the cancer has spread (metastasized) it can be used to treat the whole brain and spine. It can also be used after surgery.
Chemotherapy is the use of medications that kill cancer cells. It can be given into a vein (IV), into a muscle, by mouth, into the cerebrospinal fluid, or into the tumor itself. Chemotherapy given by itself without other treatments has not been found to effectively treat ependymoma. Chemotherapy may be used between surgeries to help shrink the tumor and make it easier to remove. Studies are being done to see if treatment with radiation and chemotherapy after surgery is beneficial.
There are clinical research trials for most types of cancer, and every stage of the disease. Clinical trials are designed to determine the value of specific treatments. Trials are often designed to treat a certain stage of cancer, either as the first form of treatment offered, or as an option for treatment after other treatments have failed to work. They can be used to evaluate medications or treatments to prevent cancer, detect it earlier, or help manage side effects. Clinical trials are extremely important in furthering our knowledge of disease. It is through clinical trials that we know what we do today, and many exciting new therapies are currently being tested. Talk to your provider about participating in clinical trials in your area. You can also explore currently open clinical trials using the OncoLink Clinical Trials Matching Service.
After treatment for childhood cancer, you will be followed closely to monitor for the cancer coming back, to manage ongoing side effects, and to transition to survivorship. At first you will have frequent appointments with providers and have ongoing tests to monitor your health, and possible recurrence of your cancer. As time goes on, these visits and testing will become less frequent. The oncology team will discuss the plan for follow up.
What can you do to live a healthy life after treatment? There is no supplement or specific food you can eat to assure good health, but there are things you can do to live healthier, prevent other diseases, detect cancers early and work with the social and emotional issues, including insurance, employment, relationships, sexual functioning, and fertility, that a prior cancer diagnosis sometimes brings with it. Your oncology team is there to support you and can help you find support resources.
It is important to have a plan for who will provide follow up care (an oncologist, survivorship doctor or primary care doctor). Talk with the team about developing a survivorship care plan or develop one using the Smart ALACC tool. Your child may benefit from being seen in a survivorship clinic. At a survivorship clinic a provider can review your child's history and provide recommendations. You can contact cancer centers in your area to see if they have a survivor's clinic or search for a clinic on OncoLink's survivorship clinic list.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania